ADVISORS MANAGEMENT GROUP INC /ADV
Position in BMY — Bristol Myers Squibb Co
CIK 842766
LA CROSSE, WI
Position in BMY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$325,149
-$17,523 QoQ
Shares Held
5,643
-0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,827
of 2,506 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADVISORS MANAGEMENT GROUP INC /ADV holds $7,828,853 across 8 Drug Manufacturers - General names. BMY ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,144 | $5,623,911 | |
| 2 | AZN |
Astrazeneca PLC
|
2,355 | $446,555 | |
| 3 | NVS |
Novartis AG
|
2,167 | $339,612 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,579 | $331,401 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
5,643 | $325,149 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,521 | $318,503 | |
| 7 | GSK |
GSK plc
|
4,634 | $242,914 | |
| 8 | ABBV |
AbbVie Inc.
|
798 | $200,808 |
All Filings in BMY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $325,149 | 5,643 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $342,672 | 5,650 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $383,351 | 7,107 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $332,161 | 7,365 | Shares | Sole | 2025-12-18 | |
| 2025-06-30 | $324,492 | 7,010 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $426,015 | 6,985 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $395,015 | 6,984 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $362,645 | 7,009 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $291,042 | 7,008 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $386,442 | 7,126 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $385,697 | 7,517 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $447,894 | 7,717 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $411,582 | 6,436 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $446,079 | 6,436 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $472,279 | 6,564 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $460,449 | 6,477 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $492,800 | 6,400 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $453,662 | 6,212 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $398,790 | 6,396 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $362,416 | 6,125 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $419,429 | 6,277 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $272,532 | 4,317 | Shares | Sole | 2021-04-14 | |
| No filing history on record for this holder in this stock. | ||||||